Koninklijke Philips N.V. stock (NL0000009538): dividend share exchange ratio set as new AI ultrasound clearance draws focus

Koninklijke Philips N.V. has fixed the 2025 dividend share exchange ratio while U.S. regulators cleared its Elevate Plus AI upgrade for EPIQ Elite and Affiniti ultrasound systems, keeping the Dutch health-technology group in focus on Euronext Amsterdam and the NYSE.

Koninklijke Philips N.V. started June trading on Euronext Amsterdam and the NYSE with investors digesting two fresh developments: the Dutch health-technology group has set the share exchange ratio for its 2025 dividend while also securing U.S. regulatory clearance for its Elevate Plus AI ultrasound upgrade for EPIQ Elite and Affiniti systems, according to a company press statement dated 06/03/2026 and supporting filings.

Philips said shareholders who opted for stock in respect of the 2025 dividend will receive 1 new common share for every 26.9341 existing shares, a ratio calculated using a volume-weighted average price of EUR 22.8640 so that the share dividend corresponds to a gross amount of approximately EUR 0.85 per share, based on a company announcement and a 6-K style disclosure dated 06/03/2026.

The group added that about 43.8% of shareholders elected to take the dividend in cash, with the remainder choosing shares, and that delivery of the new stock and payment of the cash dividend are expected to begin on 06/03/2026, according to the same communication.

Following settlement of the 2025 dividend, Philips expects its total issued share capital to rise to EUR 196,576,957.40, representing 982,884,787 common shares, as set out in the regulatory document summarizing the exchange ratio and capital impact.

Besides the dividend mechanics, Philips, headquartered in Amsterdam in the Netherlands, announced that the U.S. Food and Drug Administration has granted 510(k) clearance for Elevate Plus, an upgrade that brings AI-powered automation and advanced imaging capabilities to its EPIQ Elite and Affiniti general imaging ultrasound platforms, according to a press release archived on the companys U.S. news site with a dateline from early June 2026.

The company said Elevate Plus is designed to simplify and speed up workflows for sonographers and clinicians while maintaining diagnostic confidence, highlighting AI algorithms that can automatically perform tasks such as image optimization and certain measurement routines on supported systems.

Philips positions the Elevate Plus upgrade as part of its broader diagnostic imaging portfolio, which targets hospitals and health systems in the United States, Europe and other key markets, with the new clearance adding to prior regulatory milestones for its ultrasound and MR ranges, according to the same news archive.

On Euronext Amsterdam, the stock trades under ticker PHIA in euros, while on the New York Stock Exchange it is listed as PHG in U.S. dollars, giving investors in the Netherlands and the United States direct access to the name across time zones, based on data from exchange overview pages as of 06/03/2026.

As of 06/03/2026, the companys headquarters in Amsterdam remain its main hub for corporate functions and global management, with North America and Western Europe representing important sales regions for its connected care and diagnosis businesses, as indicated by recent investor presentations and the latest annual reporting set published earlier in 2026.

For German investors, Philips shares are also available via secondary listings such as Tradegate in euros, providing an additional access point alongside the primary Euronext Amsterdam listing, according to trading venue data reviewed on 06/03/2026.

As of: 06/03/2026

By the editorial team - specialized in equity coverage.

At a glance

• Name: Philips
• Sector/industry: Health technology and medical equipment
• Headquarters/country: Amsterdam, Netherlands
• Core markets: Europe, North America, Asia-Pacific
• Key revenue drivers: Diagnostic imaging, image-guided therapy, connected care, and personal health products
• Home exchange/listing venue: Euronext Amsterdam (PHIA), NYSE (PHG)
• Trading currency: EUR on Euronext Amsterdam, USD on NYSE

Koninklijke Philips N.V.: core business model

Philips focuses on health-technology solutions that span diagnostic imaging, image-guided therapy, monitoring and consumer health devices, with revenue largely generated from selling systems and related services to hospitals and healthcare providers worldwide.

Koninklijke Philips N.V. in peer comparison

In the global health-technology and medical equipment space, Philips competes with diversified imaging and diagnostics players such as GE HealthCare Technologies and Siemens Healthineers, which also pursue growth in AI-powered imaging and connected care systems.

For example, Siemens Healthineers, listed in Germany, reported significant revenue from its imaging segment in its most recent fiscal year and has likewise emphasized AI-based software for CT and MR scanners, while GE HealthCare, listed on Nasdaq in the United States, has highlighted double-digit growth rates in certain imaging and ultrasound subsegments in its latest quarterly update, underscoring a competitive landscape where innovation and scale are key.

Conclusion

The latest 2025 dividend share exchange ratio means Philips investors now have clear parameters for the combination of new shares and cash that will be distributed, including the resulting uplift in the companys share count.

At the same time, the FDA 510(k) clearance for the Elevate Plus AI ultrasound upgrade underlines how Philips is leaning into imaging innovation to defend and expand its position in a competitive health-technology market characterized by strong peers such as Siemens Healthineers and GE HealthCare.

How these developments feed into the companys medium-term earnings profile and capital allocation priorities will likely remain in focus for shareholders tracking both the Euronext Amsterdam and NYSE listings.

Disclaimer: This article does not constitute investment advice. The comprehensive scope of this informative article was made possible through the use of a.i.. Stocks are volatile financial instruments.